3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Squamous Intraepithelial Lesions
2
Prostatic Neoplasms
2
Papillomavirus Infections
2
Neuroblastoma
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Hemangiosarcoma
2
HIV Infections
2
Ependymoma
2
Colonic Neoplasms
2
Breast Neoplasms, Male
2
Anus Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Thromboembolism
1
Thrombocythemia, Essential
1
Stomach Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
liposomal doxorubicin
1
Watchful Waiting
1
Paclitaxel
1
Observation
1
Medical Marijuana
1
Light Coagulation
1
Laser Therapy
1
Interviews as Topic
1
Imiquimod
1
Fluorouracil
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Acquired Immunodeficiency Syndrome
×
Watchful Waiting
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts